Skip to main content
. 2015 Sep 10;68(4):1545–1560. doi: 10.1007/s10616-015-9914-5

Fig. 3.

Fig. 3

Increased chemoresistance of USP-13-Med cells. Dose–response curves of USP-13-Med and Daoy cells treated with cisplatin in vitro. Data are presented as viable (non-apoptotic) cells after 48 h of treatment with increasing log-transformed concentrations of cisplatin. The estimated LC50 values for USP-13-Med and Daoy cells were 126.4 and 3.7 µM, respectively